Sign in to continue:

Thursday, February 12th, 2026

AirAsia X Surges Ahead: Strong Buying Momentum Fuels Technical Breakout

Report Date: October 24, 2024
Broker: CGS International

Company Overview

AirAsia X Berhad is a Malaysia-based, medium to long-haul, low-cost airline. It is an affiliate of the AirAsia Group and primarily operates flights using Airbus A330-300 aircraft. The airline serves routes across the Asia Pacific and the Middle East, with flight durations exceeding four hours.

Recent Performance and Technical Analysis

The report notes that AirAsia X continued its rally following a wedge breakout that occurred on October 19, 2024. The stock’s buying interest remained robust, pushing prices to test its 2024 high on October 23, 2024. The price action was marked by a strong white candle, which is a sign of continued upward momentum.

Entry and Price Targets

  • Entry Price(s): RM1.90 – RM1.99
  • Support Levels:
    • Support 1: RM1.80
    • Support 2: RM1.70
  • Resistance Levels:
    • Resistance 1: RM2.06
    • Resistance 2: RM2.20
  • Stop Loss: RM1.79

The broker suggests that traders consider entering at the specified price range or on dips, with a recommended stop-loss set at RM1.79, slightly below the low of October 22, 2024. The upside targets are RM2.06 and RM2.20.

Technical Indicators

  • Moving Averages: The stock is supported by improving exponential moving averages (EMAs), which indicate a trend continuation.
  • MACD (Moving Average Convergence Divergence): The MACD has confirmed a golden cross, which is a positive indicator suggesting further upward movement.
  • RSI (Relative Strength Index): The RSI has strengthened, reflecting a buildup in buying momentum and supporting the outlook for continued gains.

Trading Strategy

The broker issues a “Technical Buy” recommendation for AirAsia X, noting the stock’s recent positive technical signals. The wedge breakout has paved the way for further gains, underpinned by strong buying momentum and improving technical indicators.

Traders are advised to consider long positions (buying) while maintaining a stop-loss at RM1.79. The projected upside targets of RM2.06 and RM2.20 are expected to be achievable as long as the stock maintains its current bullish trajectory, supported by the positive signals from both MACD and RSI indicators.

Shanghai Pharmaceuticals (601607.SS) Stock Analysis 2025: Buy Rating, Growth Outlook, Financials & Industry Trends

OCBC Investment Research 15 September 2025 Shanghai Pharmaceuticals: Driving Innovation Amidst Industry Headwinds — A Comprehensive Equity Analysis Overview: Shanghai Pharmaceuticals at a Crossroads Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), one of China’s top...

“Wall Street Watch: Apple’s AI Revolution and Top Stock Picks for 2025”

Comprehensive Analysis of Investment Opportunities for 2025 Comprehensive Analysis of Investment Opportunities for 2025 Broker: Maybank Research Date: January 6, 2025 Apple Inc. (AAPL) – Ushering in a New Era of AI-Driven Growth Apple...

Bermaz Auto Berhad (BAUTO) 2025-2026 Outlook: Dividend Strength, Mazda & XPeng Updates, and Malaysia Auto Market Analysis

Maybank Investment Bank Berhad Date of Report: September 17, 2025 Bermaz Auto Berhad: Dividend Strength, Cash Resilience, and New Growth Avenues Amid Automotive Market Shifts Executive Summary: Navigating Change with Strong Dividends and Asset-Light...